Skip to main content
logo
Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
262.80
+0.98 (0.37%)
Mar 13, 2026, 4:00 PM EDT - Market closed

Bio-Rad Laboratories Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,5832,5672,6712,8022,923
Revenue Growth (YoY)
0.65%-3.92%-4.67%-4.12%14.81%
Cost of Revenue
1,2431,1881,2441,2351,284
Gross Profit
1,3401,3791,4271,5671,638
Selling, General & Admin
844.3814841.7827.8877.12
Research & Development
275.6295.9247.4256.9260.64
Other Operating Expenses
172.8----
Total Operating Expenses
1,2931,1101,0891,0851,138
Operating Income
47.2269337.8482.6500.34
Interest Expense
-49-48.9-49.4-38.1-1.55
Other Non-Operating Income (Expense)
-803.52,7511,3665,239-4,902
Total Non-Operating Income (Expense)
-852.52,7021,3175,200-4,904
Pretax Income
995.5-2,343-850.1-4,7045,449
Provision for Income Taxes
-235.6498.3212.81,077-1,195
Net Income
759.9-1,844-637.3-3,6284,254
Net Income to Common
759.9-1,844-637.3-3,6284,254
Net Income Growth
----11.54%
Shares Outstanding (Basic)
2728293030
Shares Outstanding (Diluted)
2728293030
Shares Change (YoY)
-3.31%-3.41%-1.93%-1.40%0.16%
EPS (Basic)
27.87-65.36-21.82-121.79142.61
EPS (Diluted)
27.85-65.36-21.82-121.79140.83
EPS Growth
----11.35%
Free Cash Flow
906.8744.8593.181.6535.72
Free Cash Flow Growth
21.75%25.58%626.84%-84.77%12.45%
Free Cash Flow Per Share
33.2426.4020.312.7417.73
Gross Margin
51.87%53.73%53.42%55.93%56.05%
Operating Margin
1.83%10.48%12.65%17.22%17.12%
Profit Margin
29.42%-71.86%-23.86%-129.45%145.57%
FCF Margin
35.10%29.02%22.20%2.91%18.33%
EBITDA
212.6420.6483.7482.6500.34
EBITDA Margin
8.23%16.39%18.11%17.22%17.12%
EBIT
47.2269337.8482.6500.34
EBIT Margin
1.83%10.48%12.65%17.22%17.12%
Effective Tax Rate
-23.67%-21.27%-25.03%-22.89%-21.93%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q